News Briefs

✦ Federal Medicaid officials this week issued letters to Arkansas and New Hampshire informing them of the Biden administration’s formal revocation of their “community engagement” waivers. The Supreme Court on March 29 was planning to hear oral arguments related to the Trump administration’s approval of Medicaid work requirements in both states, but earlier this month removed the hearing from its docket, suggesting that previous rulings striking down work requirements could stand. View the Arkansas letter at https://bit.ly/30XShsh.

✦ The Biden administration has canceled two changes to the Part D Payment Modernization Model for 2022. One would have extended new formulary flexibilities to participating Part D plans, including in the so-called protected drug classes, in 2022. The other would have removed downside risk from the model. View a notice on the model changes at https://bit.ly/3c35Mxj.

© 2022 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

pharmacists-in-pharmacy
May 5

CMS Finalizes MA Rule Provisions, Delays Pharmacy DIR Change

READ MORE
case-files
May 5

OIG Report on Prior Authorization Denials Puts Pressure on CMS

READ MORE
analyst-looking-at-earnings
May 5

PHE Extension, Medicare AEP Boost ’22 Earnings Projections

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today